Building the Future of Health Sciences
OrbiMed seeks to invest globally in world-class healthcare companies to help drive innovation, address unmet medical needs, and improve patient outcomes.
Providing tailored financing solutions and global team resources to help build
world-class healthcare companies.
From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.
We have been investing globally for over 25 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 130 distinguished scientific, medical, investment, and other professionals manages approximately $17 billion across public and private company investments worldwide.
How We Invest
Meet Our Companies Driving Healthcare Innovation
Messenger RNA targeting to create life-saving therapeutics
ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies.
Learn More
People with cancer can’t wait. Let’s go.
SpringWorks applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.
Learn More
Pushing targeted oncology drug discovery to new heights
Treeline Biosciences is pursuing molecular targets in oncology that are validated but difficult to drug, leveraging its four pillars of drug discovery: mechanistic biology, medicinal chemistry, computational science, and structural biology and protein science.
Learn More$17B
AUM
500+
Portfolio
Companies
130+
Total
Professionals
12
Global
Locations
130+
Venture-backed
IPOs
